I
n Taiwan, the majority of carbapenem-resistant Enterobacteriaceae (CRE) isolates exhibited low-level carbapenem resistance, and with the exception of a few isolates with VIM or IMP-8 carbapenemase (6, 7, 13) , most were due to the production of extended spectrum ␤-lactamase (ESBL) and/or AmpC ␤-lactamase plus outer membrane protein porin loss (2, 7, 14) . To date, there has been only one case of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae reported in Taiwan from a patient who was hospitalized in China prior to being transferred back to Taiwan. The isolate harbored KPC-2, but the genetic background of the strain was not mentioned (3) .
We report the detection of four KPC-2-positive K. pneumoniae isolates from two patients in another hospital in Taiwan. Patient A was a 74-year-old Taiwanese male who was hospitalized in China for emergency medical treatment due to sudden cardiac arrest in 2010. He was transferred back to the coronary care unit (CCU) of a Taiwanese hospital 5 days later. He developed urinary tract infection due to a carbapenemresistant K. pneumoniae (CRKP) isolate (CRKP1) 5 days after being admitted to the CCU. Two additional CRKP isolates were recovered from the central venous catheter (CRKP3) and from urine (CRKP4) 5 weeks after admission. Unfortunately, he expired due to the occurrence of hepatoma rupture and shock. Patient B was an 87-year-old Taiwanese male who was hospitalized in the same CCU because of congestive heart failure during the same period. He developed pneumonia, and CRKP isolates were recovered from the central venous catheter tip and from a sputum specimen 1 day apart. Only his sputum isolate (CRKP2) was available for further workup. CRKP2 was isolated 19 days after CRKP1. Patient B later accepted hospice care due to the terminal stage of congestive heart failure.
The pulsed-field gel electrophoresis (PFGE) patterns of CRKP1 to CRKP4 isolates were indistinguishable (data not shown). All four isolates had the same antibiogram and were resistant to all tested ␤-lactams (Table 1) , with high ertapenem, imipenem, and meropenem MICs (Ն32 g/ml), and susceptible only to polymyxin B, tigecycline, and trimethoprim-sulfamethoxazole. All four were positive for bla KPC-2 , as well as bla and bla CTX-M , and belong to sequence type 11 (ST11) (allelic profile 3-3-1-1-1-4) (5, 8, 9, 11 ). The plasmids of CRKP1 and CRKP2 were introduced into Escherichia coli DH10B by electroporation. The pCRKP1/DH10B and pCRKP2/DH10B electrotransformants became resistant to all tested ␤-lactams (Table 1), including carbapenems (MICs of 12 to Ͼ32 g/ml), and were positive for bla KPC-2 and bla SHV-12 but not bla CTX-M . Restriction fingerprinting patterns of plasmid DNAs from the transformants were similar (Fig. 1) .
In Asia, KPC-producing K. pneumoniae was first detected in a 2004 isolate from China (12) , where KPC-2-producing Enterobacteriaceae bacteria were subsequently disseminated in different regions (1, 10, 15) . ST11 was found to be the predominant KPC-2-producing K. pneumoniae sequence type isolated from multiple cities of China (10) . Those ST11 isolates also carried a combination of SHV-type and CTX-M-type ESBLs and AmpC ␤-lactamases (10).
It is possible that patient A acquired KPC-producing K. pneumoniae during his hospitalization in China and that the strain was then transmitted to patient B in the same ward in Taiwan. Although the prevalence of carbapenem-resistant Enterobacteriaceae in Taiwan has remained low (2, 7, 14) , the emergence of KPCproducing K. pneumoniae is worrisome since multidrug-resistant Enterobacteriaceae bacteria are already prevalent in Taiwan, neces- sitating increased carbapenem use. Careful monitoring systems need to be implemented and should include patients transferred from hospitals abroad.
